Global (United States, European Union and China) Autoimmune Drugs Market Research Report 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Autoimmune Drugs Revenue
• 1.4 Market by Type
  • 1.4.1 Global Autoimmune Drugs Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Rheumatoid Arthritis (RA)
  • 1.4.3 Multiple Sclerosis (MS)
  • 1.4.4 Psoriasis
  • 1.4.5 Inflammatory Bowel Disease (IBD)
  • 1.4.6 Ankylosing Spondylitis (AS)
  • 1.4.7 Systemic Lupus Erythematosus (SLE)
• 1.5 Market by Application
  • 1.5.1 Global Autoimmune Drugs Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Homecare Settings
  • 1.5.4 Specialty Clinics
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Autoimmune Drugs Market Perspective (2015-2026)
• 2.2 Global Autoimmune Drugs Growth Trends by Regions
  • 2.2.1 Autoimmune Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Autoimmune Drugs Historic Market Share by Regions (2015-2020)
  • 2.2.3 Autoimmune Drugs Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Autoimmune Drugs Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Autoimmune Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Autoimmune Drugs Players by Market Size
  • 3.1.1 Global Top Autoimmune Drugs Players by Revenue (2015-2020)
  • 3.1.2 Global Autoimmune Drugs Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Autoimmune Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Autoimmune Drugs Market Concentration Ratio
  • 3.2.1 Global Autoimmune Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Autoimmune Drugs Revenue in 2019
• 3.3 Autoimmune Drugs Key Players Head office and Area Served
• 3.4 Key Players Autoimmune Drugs Product Solution and Service
• 3.5 Date of Enter into Autoimmune Drugs Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Autoimmune Drugs Historic Market Size by Type (2015-2020)
• 4.2 Global Autoimmune Drugs Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Autoimmune Drugs Market Size by Application (2015-2020)
• 5.2 Global Autoimmune Drugs Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Autoimmune Drugs Market Size (2015-2020)
• 6.2 Autoimmune Drugs Key Players in North America (2019-2020)
• 6.3 North America Autoimmune Drugs Market Size by Type (2015-2020)
• 6.4 North America Autoimmune Drugs Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Autoimmune Drugs Market Size (2015-2020)
• 7.2 Autoimmune Drugs Key Players in Europe (2019-2020)
• 7.3 Europe Autoimmune Drugs Market Size by Type (2015-2020)
• 7.4 Europe Autoimmune Drugs Market Size by Application (2015-2020)

8 China

• 8.1 China Autoimmune Drugs Market Size (2015-2020)
• 8.2 Autoimmune Drugs Key Players in China (2019-2020)
• 8.3 China Autoimmune Drugs Market Size by Type (2015-2020)
• 8.4 China Autoimmune Drugs Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Autoimmune Drugs Market Size (2015-2020)
• 9.2 Autoimmune Drugs Key Players in Japan (2019-2020)
• 9.3 Japan Autoimmune Drugs Market Size by Type (2015-2020)
• 9.4 Japan Autoimmune Drugs Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Autoimmune Drugs Market Size (2015-2020)
• 10.2 Autoimmune Drugs Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Autoimmune Drugs Market Size by Type (2015-2020)
• 10.4 Southeast Asia Autoimmune Drugs Market Size by Application (2015-2020)

11 India

• 11.1 India Autoimmune Drugs Market Size (2015-2020)
• 11.2 Autoimmune Drugs Key Players in India (2019-2020)
• 11.3 India Autoimmune Drugs Market Size by Type (2015-2020)
• 11.4 India Autoimmune Drugs Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Autoimmune Drugs Market Size (2015-2020)
• 12.2 Autoimmune Drugs Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Autoimmune Drugs Market Size by Type (2015-2020)
• 12.4 Central & South America Autoimmune Drugs Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Eli Lilly
  • 13.1.1 Eli Lilly Company Details
  • 13.1.2 Eli Lilly Business Overview
  • 13.1.3 Eli Lilly Autoimmune Drugs Introduction
  • 13.1.4 Eli Lilly Revenue in Autoimmune Drugs Business (2015-2020))
  • 13.1.5 Eli Lilly Recent Development
• 13.2 GSK
  • 13.2.1 GSK Company Details
  • 13.2.2 GSK Business Overview
  • 13.2.3 GSK Autoimmune Drugs Introduction
  • 13.2.4 GSK Revenue in Autoimmune Drugs Business (2015-2020)
  • 13.2.5 GSK Recent Development
• 13.3 AbbVie
  • 13.3.1 AbbVie Company Details
  • 13.3.2 AbbVie Business Overview
  • 13.3.3 AbbVie Autoimmune Drugs Introduction
  • 13.3.4 AbbVie Revenue in Autoimmune Drugs Business (2015-2020)
  • 13.3.5 AbbVie Recent Development
• 13.4 Johnson & Johnson
  • 13.4.1 Johnson & Johnson Company Details
  • 13.4.2 Johnson & Johnson Business Overview
  • 13.4.3 Johnson & Johnson Autoimmune Drugs Introduction
  • 13.4.4 Johnson & Johnson Revenue in Autoimmune Drugs Business (2015-2020)
  • 13.4.5 Johnson & Johnson Recent Development
• 13.5 Biogen
  • 13.5.1 Biogen Company Details
  • 13.5.2 Biogen Business Overview
  • 13.5.3 Biogen Autoimmune Drugs Introduction
  • 13.5.4 Biogen Revenue in Autoimmune Drugs Business (2015-2020)
  • 13.5.5 Biogen Recent Development
• 13.6 Amgen
  • 13.6.1 Amgen Company Details
  • 13.6.2 Amgen Business Overview
  • 13.6.3 Amgen Autoimmune Drugs Introduction
  • 13.6.4 Amgen Revenue in Autoimmune Drugs Business (2015-2020)
  • 13.6.5 Amgen Recent Development
• 13.7 Pfizer
  • 13.7.1 Pfizer Company Details
  • 13.7.2 Pfizer Business Overview
  • 13.7.3 Pfizer Autoimmune Drugs Introduction
  • 13.7.4 Pfizer Revenue in Autoimmune Drugs Business (2015-2020)
  • 13.7.5 Pfizer Recent Development
• 13.8 Roche
  • 13.8.1 Roche Company Details
  • 13.8.2 Roche Business Overview
  • 13.8.3 Roche Autoimmune Drugs Introduction
  • 13.8.4 Roche Revenue in Autoimmune Drugs Business (2015-2020)
  • 13.8.5 Roche Recent Development
• 13.9 Baxter
  • 13.9.1 Baxter Company Details
  • 13.9.2 Baxter Business Overview
  • 13.9.3 Baxter Autoimmune Drugs Introduction
  • 13.9.4 Baxter Revenue in Autoimmune Drugs Business (2015-2020)
  • 13.9.5 Baxter Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer